|
Stories from the dialysis comunity across the globe.
|
|
New class of antimicrobial drugs active against Staph aureus discovered. |
 |
 |
|
Ohio State: In two separate studies, researchers at The Ohio State University Wexner Medical Center have discovered a new class of treatment against methicillin-resistant Staphylococcus aureus (MRSA) as well as evidence of a growing need to quickly genotype individual strains of the organism most commonly referred to as the "superbug."
|
|
|
Off-topic weekend tech: We're NASA and we know it (from mid-August). |
|
|
|
Huffpo (Sci Am): Ok, a bit dated (from August), but still inspirational.
|
|
Eggs made from skin cells fertilized with male mouse sperm and give rise to seemingly normal mice. |
|
|
|
BBC: Stem cells made from skin have become "grandparents" after generations of life were created in experiments by scientists in Japan. The cells were used to create eggs, which were fertilised to produce baby mice. These later had their own babies.
|
|
|
Incenter short daily hemodialysis associated with INCREASED mortality. |
|
|
|
Kidney Int (Suri et al): Mean weekly treatment time was 15.7?h for daily and 11.9?h for conventional patients. During 1382 patient-years of follow-up, 170 patients died. Those receiving daily hemodialysis had a significantly higher mortality rate than those receiving conventional hemodialysis (15.6 and 10.9 deaths per 100 patient-years, respectively: hazard ratio 1.6). Similar results were found in prespecified subgroup and sensitivity analyses. Unlike previous studies, we found that in-center daily hemodialysis was not associated with any mortality benefit. Thus, decisions to undertake daily hemodialysis should be based on quality-of-life improvements, rather than on claims of improved survival.
|
|
Subcutaneous implantable defibrillator avoids the need for intravenous leads. |
|
|
|
Science Blog: A new ground-breaking technology was recently used at the University of Ottawa Heart Institute (UOHI) where two cardiologists, Dr. David Birnie and Dr. Pablo Nery, implanted a new innovative leadless defibrillator, the subcutaneous implantable cardioverter defibrillator (S-ICD), to a 18 year-old patient. Under Health Canada’s special access program, this was only the third time this new type of ICD had been implanted in Canada.
|
|
|
|
|
<< Start < Prev 461 462 463 464 465 466 467 468 469 470 Next > End >>
|
|
Page 466 of 4210 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
